Kerstin Menck

17PUBLICATIONS
31CO-AUTHORS
Solid tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Nov 17, 2025
Pharmacological inhibition of myostatin effectively ameliorates osteolytic lesions in syngeneic and xenograft breast cancer mouse models.

Julia Reinhardt, Berno Dankbar, Fabienne Geers

|Aug 20, 2025
Syntenin Controls Extracellular Vesicle-Induced Tumour Migration by Regulating the Expression of Adhesion Proteins on Small Extracellular Vesicles.

Barnabas Irmer, Allegra Angenendt, Luc Camoin

|Jan 18, 2025
Consensus molecular subtyping of colorectal carcinoma brain metastases reveals a metabolic signature associated with poor patient survival.

Barnabas Irmer, Darius Wlochowitz, Carolin Krekeler

|Mar 07, 2024
PD-L1 on large extracellular vesicles is a predictive biomarker for therapy response in tissue PD-L1-low and -negative patients with non-small cell lung cancer.

Nadja Schöne, Marcel Kemper, Kerstin Menck

|Aug 12, 2023
Complete Metabolic Response to Combined Immune Checkpoint Inhibition after Progression of Metastatic Colorectal Cancer on Pembrolizumab: A Case Report.

Carolin Krekeler, Klaus Wethmar, Jan-Henrik Mikesch

|Jun 09, 2023
BRD4 inhibition sensitizes diffuse large B-cell lymphoma cells to ferroptosis.

Anja Schmitt, Melanie Grimm, Nina Kreienkamp

Pageof 3

Frequent Collaborators

1 joint publications

Astrid Wachter

1 joint publications

Matthias Schulz

1 joint publications

Bawarjan Schatlo

1 joint publications

Ali Badache